- Tekcapital has acquired the exclusive license to a patent-pending technology for the measurement of glucose in breath from Purdue University. Financial details were not immediately available.

The technology addresses the need for a safe, fast, accurate and non-invasive method for health professionals to analyse samples of glucose in exhaled breath and adds to Tekcapital's portfolio of patents for the non-invasive measurement of glucose which also includes a technology to test for glucose in saliva.

Separately, Tekcapital has appointed Allenby Capital Ltd as its Nominated Adviser and Joint Broker with immediate effect. Optiva Securities Limited will continue as Joint Broker.

Story provided by